Avasimibe, a sterol O-acyltransferase 1 inhibitor, has also been utilized to prevent cholesterol esterification, which raises cholesterol levels and impairs T-cell effector function and proliferation, improving the anti-tumor impact [96]. The gene discussed is SOAT1; the disease is neoplasm.